Chandra Bhagat Pharma Limited (BOM:542934)

Market Cap	444.78M
Revenue (ttm)	867.16M
Net Income (ttm)	8.58M
Shares Out	7.55M
EPS (ttm)	1.14
PE Ratio	51.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	7,550
Open	57.00
Previous Close	56.00
Day's Range	57.00 - 57.00
52-Week Range	46.15 - 110.75
Beta	-0.62
RSI	50.90
Earnings Date	May 22, 2025

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology, etc. The company also promotes and markets specialty chemicals; and active pharmaceuticals ingredients and its intermediates....

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1944
• Employees: 37
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 542934

Financial Performance

In 2024, Chandra Bhagat Pharma's revenue was 867.16 million, a decrease of -61.03% compared to the previous year's 2.23 billion. Earnings were 8.58 million, a decrease of -43.95%.